Actualités et vidéos - NUVASIVE INC.

NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting PR Newswire SAN DIEGO, Aug. 30, 2023 SAN DIEGO , Aug. 30, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Scoliosis Research Society (SRS) as a double diamond sponsor and will attend the 58 th Annual...

NuVasive Announces Second Quarter 2023 Financial Results PR Newswire SAN DIEGO, Aug. 2, 2023 – U.S. Cervical continues to deliver greater than 20% year-over-year growth– – International net sales grew 6.8% as reported and 9.8% on a constant currency basis– SAN DIEGO , Aug. 2, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results PR Newswire SAN DIEGO, July 24, 2023 SAN DIEGO , July 24, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it will release its second quarter 2023 results on Wednesday, August 2, 2023 , after the close of the market. NuVasive will hold a conference call...

NuVasive Announces First Quarter 2023 Financial Results PR Newswire SAN DIEGO, May 10, 2023 – Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis – – U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc– SAN DIEGO , May 10, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with...

NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results PR Newswire SAN DIEGO, May 4, 2023 SAN DIEGO , May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023 , after the close of the market. NuVasive will hold a conference call on...

NuVasive to Participate in Upcoming Global Spine Conferences PR Newswire SAN DIEGO, April 11, 2023 SAN DIEGO , April 11, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its continued participation at various global conferences throughout April and May. "Our participation in spine conferences around the world reflects our belief in...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients PR Newswire SAN DIEGO, March 20, 2023 SAN DIEGO , March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice...

NuVasive to Participate in Upcoming Spine Society Annual Conferences PR Newswire SAN DIEGO, March 14, 2023 SAN DIEGO , March 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its continued participation at the 2023 Spine Summit held March 16-19 in Miami and the International Meeting on Advanced Spine Techniques (IMAST) held March...

NuVasive Celebrates 20-Year Milestone of the XLIF Procedure PR Newswire SAN DIEGO, March 13, 2023 NuVasive commemorates industry-defining innovation in the lateral procedural segment SAN DIEGO , March 13, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the 20-year milestone achievement of its lateral lumbar procedure, extreme lateral...

NuVasive to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, Feb. 27, 2023 SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will participate in upcoming investor conferences and will be joined by Globus Medical management to discuss the two companies' recent merger...

NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance PR Newswire SAN DIEGO, Feb. 22, 2023 – Full-year 2022 net sales grew 5.5% as reported, 8.5% on a constant currency basis – – Continued strong international growth in 2022 – – U.S. cervical delivers growth of greater than 20% year-over-year driven by C360 – – 2,000+ Pulse cases performed worldwide since commercial launch – SAN DIEGO , Feb. 22, 2023 /PRNewswire/ -- NuVasive, Inc....

NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty PR Newswire SAN DIEGO, Feb. 21, 2023 Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO , Feb. 21, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received 510(k) clearance from the U.S. Food and...

ALERT: The M&A Class Action Firm Announces the Investigation of NuVasive, Inc. - NUVA PR Newswire NEW YORK, Feb. 13, 2023 NEW YORK , Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City , is investigating NuVasive, Inc. (NASDAQ:...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of NuVasive, Inc. PR Newswire NEW YORK, Feb. 9, 2023 NEW YORK , Feb. 9, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by NuVasive, Inc. (NASDAQ: NUVA) and its board of directors concerning the proposed acquisition of the company by Globus Medical, Inc. (NYSE: GMED). Stockholders will receive 0.75 shares of Globus Medical Class A common stock for each share of NuVasive, Inc. stock that they...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NuVasive, Inc. (NASDAQ: NUVA) to Globus Medical, Inc. for 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock is fair to NuVasive shareholders. Halper Sadeh encourages NuVasive shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The...

NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2022 Results PR Newswire SAN DIEGO, Jan. 30, 2023 SAN DIEGO , Jan. 30, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full-year 2022 results on Wednesday, February 22, 2023 , after the close of the market....

NuVasive to Participate in the 41st Annual J.P. Morgan Healthcare Conference PR Newswire SAN DIEGO, Dec. 12, 2022 SAN DIEGO , Dec. 12, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 12,...

NuVasive Showcases Latest Innovation in Virtual Global Event PR Newswire SAN DIEGO, Nov. 17, 2022 SAN DIEGO , Nov. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, held a virtual event yesterday showcasing the Company's latest innovation across its market-leading 360 portfolios. "Changing the lives of patients around the globe is the foundation of...